Literature DB >> 4596673

Treatment of the cerebral manifestations of arteriosclerosis with cyclandelate.

J Young, P Hall, C Blakemore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4596673     DOI： 10.1192/bjp.124.2.177

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  3 in total

1.  Specific effects of cyclandelate on memory.

Authors:  J Ananth
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency. A study in general practice comprising 2772 patients.

Authors:  Y Memin
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.

Authors:  G Nappi; G Sandrini; G Savoini; A Cavallini; C de Rysky; G Micieli
Journal:  Drugs       Date:  1987       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.